112
Participants
Start Date
August 31, 2008
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Lovastatin
Lovastatin 40 mg daily (2 tablets of 20 mg each, p.o.), during twelve months until the end of the study, or before the end of the study if any AIDS defining disease or toxicity appear
placebo
Placebo will be administered daily (2 tablets which will look externally identical to intervention: wrapped in the same way, with the same size, shape and color), during twelve months until the end of the study, or before the end of the study if any AIDS defining disease or toxicity appear
Group of Immunovirology, Research Universitary Center, University of Antioquia, Medellín
Collaborators (1)
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)
OTHER_GOV
Laboratorio Clínico Congregación Mariana
OTHER
Laboratorios Laproff S.A.
INDUSTRY
Humax Pharmaceutical
INDUSTRY
Universidad de Antioquia
OTHER